Search research articles
Contact Us
Filters
Showing results (931-940 of 946) with videos related to
Page
of 95
Sort By:
JAMA
|
February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
Steven Y C Tong, David C Lye, Dafna Yahav, et al.
The Lancet. Diabetes & Endocrinology
|
August 2, 2014
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort
Roseanne O Yeung, Yuying Zhang, Andrea Luk, et al.
Cell Reports. Medicine
|
February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
Marios Koutsakos, Louise C Rowntree, Luca Hensen, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset
Benjamin D Heavner, Marsha M Wheeler, Jesse D Bengtsson, et al.
JAMA Network Open
|
November 4, 2024
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement
Zachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, et al.
JAMA Network Open
|
July 31, 2023
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement
Emily G McDonald, Gloria Aggrey, Abdullah Tarik Aslan, et al.
Journal of Neurointerventional Surgery
|
September 19, 2025
Procedure duration predicts outcomes more than prehospital delay in endovascular stroke treatment
Hassan Saad, Andrew B Koo, Jonathan A Grossberg, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 95
Search research articles
Search
Showing results (931-940 of 946) with videos related to
Sort By:
Page
of 95
JAMA
|
February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
Steven Y C Tong, David C Lye, Dafna Yahav, et al.
The Lancet. Diabetes & Endocrinology
|
August 2, 2014
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort
Roseanne O Yeung, Yuying Zhang, Andrea Luk, et al.
Cell Reports. Medicine
|
February 10, 2021
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
Marios Koutsakos, Louise C Rowntree, Luca Hensen, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset
Benjamin D Heavner, Marsha M Wheeler, Jesse D Bengtsson, et al.
JAMA Network Open
|
November 4, 2024
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement
Zachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, et al.
JAMA Network Open
|
July 31, 2023
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement
Emily G McDonald, Gloria Aggrey, Abdullah Tarik Aslan, et al.
Journal of Neurointerventional Surgery
|
September 19, 2025
Procedure duration predicts outcomes more than prehospital delay in endovascular stroke treatment
Hassan Saad, Andrew B Koo, Jonathan A Grossberg, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
NEJM Evidence
|
February 6, 2024
A Randomized Trial of Nafamostat for Covid-19
Susan C Morpeth, Balasubramanian Venkatesh, James A Totterdell, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
Page
of 95